Myocardial and microvascular inflammation/infection in patients with HIV-associated pulmonary artery hypertension

AIDS

Volumn 28, Issue 17, 2014, Pages 2541-2549

  Frustaci, Andrea ^a,b   Petrosillo, Nicola ^c   Vizza, Dario ^a   Francone, Marco ^a   Badagliacca, Roberto ^a   Verardo, Romina ^b   Fedele, Francesco ^a   Ippolito, Giuseppe ^c   Chimenti, Cristina ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Cellular and Molecular Cardiology Lab   (United States)

^c Infectious Diseases Associates   (United States)

Author keywords

HIV; Myocarditis; Pulmonary artery hypertension; Viruses

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1; VIRUS PROTEIN;

ADENOVIRIDAE; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CYTOMEGALOVIRUS; ENTEROVIRUS; EPSTEIN BARR VIRUS; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE BIOPSY; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FUNCTION; HEPATITIS C VIRUS; HUMAN; HUMAN ADENOVIRUS 1; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PARVOVIRUS B19; IMMUNOHISTOLOGY; INFLUENZA VIRUS A; INFLUENZA VIRUS B; LUNG ARTERY PRESSURE; MALE; MICROANEURYSM; MICROVASCULITIS; MIDDLE AGED; MYOCARDITIS; NEW YORK HEART ASSOCIATION CLASS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; VASCULITIS; CLASSIFICATION; COINFECTION; COMPLICATION; HEART MUSCLE; ISOLATION AND PURIFICATION; MICROVASCULATURE; PATHOLOGY; VIROLOGY; VIRUS;

ADULT; COINFECTION; FEMALE; HIV INFECTIONS; HUMANS; HYPERTENSION, PULMONARY; MALE; MICROVESSELS; MIDDLE AGED; MYOCARDITIS; MYOCARDIUM; VASCULITIS; VIRUSES;

EID: 84927741216     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000426     Document Type: Article

References (29)

1. Simonneau G. Robbins IM. Beghetti M. Channick RN. Delcroix M. Denton CP. et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54 (1 Suppl): S43-S54.
2. Speich R. Jenni R. Opravil M. Pfab M. Russi EW. Primary pulmonary hypertension in HIV infection. Chest 1991; 100: 1268-1271.
3. Opravil M. Sereni D. Natural history of HIV-associated pulmonary arterial hypertension: trends in the HAART era. AIDS 2008; 22: 35-40.
4. Degano B. Guillaume M. Savale L. Montani D. Jais X. Yaici A. et al. HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era. AIDS 2010; 24: 67-75.
5. Zuber JP. Calmy A. Evison JM. Hasse B. Schiffer V. Wagels T. et al. Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis 2004; 38: 1178-1185.
6. Mette SA. Palevsky HI. Pietra GG. Williams TH. Bruder E. Prestipino AJ. et al. Primary pulmonary hypertension in association with human immunodeficiency virus infection. A possible viral etiology for some forms of hypertensive pulmonary arteriopathy. Am Rev Respir Dis 1992; 1455: 1196-1200.
7. Almodovar S. Knight R. Allshouse AA. Roemer S. Lozupone C. McDonald D. et al. Human Immunodeficiency Virus nef signature sequences are associated with pulmonary hypertension. AIDS Res Hum Retroviruses 2012; 28: 607-618.
8. Lee SW. Lee YM. Bae SK. Murakami S. Yun Y. Kim KW. Human hepatitis B virus X protein is a possible mediator of hypoxiainduced angiogenesis in hepatocarcinogenesis. Biochem Biophys Res Commun 2000; 2682: 456-461.
9. Cool CD. Rai PR. Yeager ME. Hernandez-Saavedra D. Serls AE. Bull TM. et al. Expression of human herpes virus 8 in primary pulmonary hypertension. N Engl J Med 2003; 34912: 1113-1122.
10. Friedrich MG. Sechtem U. Schulz-Menger J. Holmvang G. Alakija P. Cooper LT. et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol 2009; 53: 1475-1487.
11. Chimenti C. Kajstura J. Torella D. Urbanek K. Heleniak H. Colussi C. et al. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res 2003; 93: 604-613.
12. Aretz HT. Billingham ME. Edwards WD. Factor SM. Fallon JT. Fenoglio JJ Jr. et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1987; 1: 3-14.
13. Maisch B. Portig I. Ristic A. Hufnagel G. Pankuweit S. Definition of inflammatory cardiomyopathy (myocarditis): on the way to consensus. A status report. Herz 2000; 25: 200-209.
14. Noutsias M. Seeberg B. Schultheiss HP. Kühl U. Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation 1999; 99: 2124-2131.
15. Frustaci A. Calabrese F. Chimenti C. Pieroni M. Thiene G. Maseri A. Lone hepatitis C virus myocarditis responsive to immunosuppressive therapy. Chest 2002; 122: 1348-1356.
16. Frustaci A. Chimenti C. Calabrese F. Pieroni M. Thiene G. Maseri A. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 2003; 107: 857-863.
17. Galiegrave; N. Ghofrani HA. Torbicki A. Barst RJ. Rubin LJ. Badesch G. et al. Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005; 353: 2148-2157.
18. [Erratum in: N Engl J Med 2006;354: 2400-2401].
19. Rubin LJ. Badesch DB. Barst RJ. Galiegrave; N. Black C M. Keogh A. et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002; 346: 896-903[Erratum in: N Engl J Med 2002;346: 1258].
20. Chimenti C. Calabrese F. Thiene G. Pieroni M. Maseri A. Frustaci A. Inflammatory left ventricular microaneurysms as a cause of apparently idiopathic ventricular tachyarrhythmias. Circulation 2001; 104: 168-173.
21. Vallbracht KB. Schwimmbeck PL. Seeberg B. Kühl U. Schultheiss HP. Endothelial dysfunction of peripheral arteries in patients with immunohistologically confirmed myocardial inflammation correlates with endothelial expression of human leukocyte antigens and adhesion molecules in myocardial biopsies. J Am Coll Cardiol 2002; 40: 515-520.
22. Kühl U. Pauschinger M. Noutsias M. Seeberg B. Boch T. Lassner D. et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 2005; 111: 887-893.
23. Nicastri E. Vizza CD. Carletti F. et al. Human herpesvirus 8 and pulmonary hypertension. Emerg Infect Dis 2005; 11: 1480-1482.
24. Matsumori A. Yutani C. Ikeda Y. Kawai S. Sasayama S. Hepatitis C virus from the hearts of patients with myocarditis and cardiomyopathy. Lab Investig 2000; 80: 437-442.
25. Cicalini S. Chinello P. Petrosillo N. HIV infection and pulmonary arterial hypertension. Expert Rev Respir Med 2011; 5: 257-266.
26. Kühl U. Lassner D. von Schlippenbach J. Poller W. Schultheiss HP. Interferon-Beta improves survival in enterovirus-associated cardiomyopathy. J Am Coll Cardiol 2012; 60: 1295-1296.
27. Feeney ER. Chung RT. Antiviral treatment of hepatitis C. BMJ 2014; 349: g3308.
28. Schultheiss HP. Kühl U. Cooper LT. The management of myocarditis. Eur Heart J 2011; 32: 2616-2625.
29. Frustaci A. Russo MA. Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virusnegative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 2009; 30: 1995-2002.